Back to today’s briefing

Story perspectives

Trump Considers Major Shift: Marijuana Reclassification Ahead?

8/10/2025

29 7

Summary

Trump Considers Marijuana Reclassification

President Donald Trump is contemplating a major shift in marijuana policy, potentially reclassifying it from a Schedule I to a Schedule III drug. This decision, influenced by substantial donations from cannabis companies during a $1 million fundraiser in New Jersey, could relax regulations and invigorate the booming industry, reflecting growing public support for legalization despite his previous skepticism.

Summary

Trump Signs HALT Act

President Trump has signed the HALT Fentanyl Act, a significant move that not only targets fentanyl analogues but also opens doors for research on Schedule I drugs, including marijuana. This pivotal legislation could reshape the landscape of medical cannabis studies, potentially altering its legal status and accessibility across the United States.

History

Historical Context

The Controlled Substances Act of 1970 classified marijuana as a Schedule I drug, severely restricting its research and medical use. Since then, advocacy groups like NORML have pushed for legalization, reflecting a shift in public opinion; a 2021 Gallup poll indicated 68% support for legalization. Trump's potential reclassification could reshape U.S. drug policy, enhancing medical research and accessibility.

1 of 3

Trump Considers Marijuana Reclassification

President Donald Trump is contemplating a major shift in marijuana policy, potentially reclassifying it from a Schedule I to a Schedule III drug. This decision, influenced by substantial donations from cannabis companies during a $1 million fundraiser in New Jersey, could relax regulations and invigorate the booming industry, reflecting growing public support for legalization despite his previous skepticism.

1 / 3